Clinical Trials Logo

Decrease in Night Vision clinical trials

View clinical trials related to Decrease in Night Vision.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04004507 Completed - Clinical trials for Disturbance; Vision, Loss

Single Dose Study of Phentolamine Mesylate Eye Drops in Patients With Severe Night Vision Disturbances

SNV
Start date: August 2007
Phase: Phase 2
Study type: Interventional

The objectives of this study are: - To assess the effect of ophthalmic phentolamine mesylate in mesopic conditions on the four endpoints: 1. Contrast sensitivity 2. Low contrast visual acuity 3. Wavefront aberrometry 4. Subjective questionnaire - To assess the safety of ophthalmic phentolamine mesylate

NCT ID: NCT01703559 Completed - Clinical trials for Disturbance; Vision, Loss

The Safety and Efficacy of Phentolamine Mesylate Ophthalmic Solution in Subjects With Severe Night Vision Disturbances

Start date: September 9, 2011
Phase: Phase 2
Study type: Interventional

The objectives of this study are: - To evaluate the efficacy of phentolamine mesylate 0.5% and 1.0% ophthalmic solution (Nyxol) in the treatment of night vision complaints, including reduced contrast sensitivity - To evaluate the ocular and systemic safety of phentolamine mesylate 0.5% and 1.0% ophthalmic solution (Nyxol) compared to its vehicle, a sterile, isotonic, buffered aqueous solution containing mannitol and sodium acetate